Indigo Diabetes Incorporates Fully Owned Subsidiary in the US and Appoints Peter J. Devlin as President, Indigo Medical US Inc.

Indigo Appoints Mike Malecha as VP Digital

We are pleased to announce the appointment of Mike Malecha as VP Digital Will lead the development of software digital strategies, ensuring compliant and secure data management for Indigo’s continuous metabolite monitoring device Brings over 15 years’ experience...
Indigo Diabetes Incorporates Fully Owned Subsidiary in the US and Appoints Peter J. Devlin as President, Indigo Medical US Inc.

Indigo Appoints Emmet Lydon as Chief Operating Officer

We are pleased to announce the appointment of Emmet Lydon as Chief Operating Officer BELGIUM – Ghent, 10 May 2022  – Indigo Diabetes N.V. (‘Indigo’ or the ‘Company’), a pioneering developer of medical solutions using nanophotonics, today announces the appointment of...
Indigo Diabetes Incorporates Fully Owned Subsidiary in the US and Appoints Peter J. Devlin as President, Indigo Medical US Inc.

Indigo Diabetes Business Update

BELGIUM – Ghent, December 21, 2021 – Indigo Diabetes N.V. (‘Indigo’ or the ‘Company’), a pioneering developer of medical solutions using nanophotonics, today provides an update on recent and ongoing business activities. Clinical study progress The GLOW study, which...